Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
La percezione dello stimolo odoroso: dalla periferia al centro Glomerulo olfattivo e funzione delle cellule non neuronali
Astrociti localizzati
nelle regioni limitro-
fe del glomerulo
olfattivo(4)
Cellule Microgliali
localizzate nelle regioni
limitrofe del glomerulo
Neuroni del olfattivo(8)
bulbo olfattivo
La fisiologica regolazione delle cellule
non neuronali è garantita dalla
Palmitoiletanolamide, sostanza lipidica
presente nei tessuti cerebrali nota per la
I Mastociti si localizzano
sua capacità di esercitare una moltitudine di
sia nell’epitelio nasale che
nel bulbo olfattivo(9) funzioni fisiologiche legate all'omeostasi
neurometabolica dei tessuti.(10)
Contatto delle particelle
virali con il neuroepitelio
olfattivo(11)
Rapida invasione del bulbo
olfattivo (SNC) da parte del
virus(12)
neuronali con rilascio di
mediatori pro-neuroinfiam-
matori (TNF-α; IFN-y; IL-1
β; SAA1)(13; 14)
Stress Ossidativo sono causa
dell’alterata trasduzione e trasmissione
dell’impulso nervoso(15)
Anosmia
ASTROCITA
MICROGLIA
MICROGLIA Iposmia
Neuroni del
bulbo olfattivo
Disosmia
I disordini dell’olfatto interessano fino al 90% dei soggetti con Parkinson e circa il 20-45% dei
soggetti con Sclerosi Multipla (16; 17) Analisi istologica del bulbo olfattivo.(3)
I disordini dell’olfatto sono un segno precoce e diagnostico di neuroinfiammazione del sistema
nervoso centrale
GFAP IBA1
Effetti dell’iperattivazione delle cellule non
neuronali nel bulbo olfattivo:
Risultato
pa
pa
5 25 6 48 > 31 Normosmia
i
n° d
n° d
28-30 Lieve iposmia
5
(borderline normosmia)
17-27 Iposmia
< 17 Anosmia
51
20 25
ANTI-NEUROINFIAMMATORIO
ANTIOSSIDANTE
NEUROTROFICO
Ġlìalia® 20 bustine
Microgranuli per somministrazione sublinguale
Composizione per ogni bustina:
Palmitoiletanolamide 700.00 mg
Luteolina 70,00 mg SENZA GLUTINE E GLUCOSIO
Sotto forma fisica di ultra-microcomposito PEALut® (770,00 mg) NATURALMENTE PRIVO DI LATTOSIO
Grazie alla sua azione Ġlìalia® risulta utile nel recupero funzionale del declino cognitivo(29)
1) Maurizi M. Clinica otorinolaringoiatrica. Basi anatomo-funzio- ruses: Underestimated Opportunistic Pathogens of the Central 22) Cordaro M, Cuzzocrea S,
nali, patologiche e cliniche delle grandi sindromi e delle ma- Nervous System?. Viruses. 2019;12(1):14. Published 2019 Crupi R. An Update of Pal-
lattie. Piccin-Nuova Libraria. 2007 12) Woo-Jung Song, Christopher K M Hui, James H Hull, Surinder S mitoylethanolamide and
2) Dubayle D, Servière J, Menétrey D. The effects of viscero-somatic Birring, Lorcan McGarvey, Stuart B Mazzone, Kian Fan Chung .Con- Luteolin Effects in Precli-
interactions on thalamic mast cell recruitment in cystitic rats. fronting COVID-19-associated cough and the post-COVID nical and Clinical Studies
J Neuroimmunol. 2007;190(1-2):18-27 syndrome: role of viral neurotropism, neuroinflammation, and of Neuroinflammatory
3) Marius Schwabenland, Henrike Salié, Jovan Tanevski, Saskia Killmer, neuroimmune responses. Lancet Respir Med. 2021 Events. Antioxidants 2020,
Marilyn Salvat Lago, Alexandra Emilia Schlaak, Lena Mayer, Jakob 13) Steardo L, Steardo L, Zorec R, Verkhratsky A. Neuroinfection may 23) Siracusa R, Impellizzeri D,
Matschke Klaus Püschel, Antonia Fitzek, Benjamin Ondruschka, Hen- potentially contribute to pathophysiology and clinical manife- Cordaro M, Crupi R, Esposi-
rik E Mei, Tobias Boettler, Christoph Neumann-Haefelin, Maike Hof- stations of COVID-19. Acta Physiologica 2020; to E, Petrosino S, Cuzzocrea
mann, Angele Breithaupt, Nafiye Genc, Christine Stadelmann, Julio 14) Afshin A Divani, Sasan Andalib, Mario Di Napoli, Simona Lattanzi, M S. Anti-inflammatory and
Saez-Rodriguez, Peter Bronsert, Klaus-Peter Knobeloch 1, Thomas Shazam Hussain, José Biller, Louise D McCullough, M Reza Azar- neuroprotective effects of co-ultraPEALut in a mouse model
Blank 1, Robert Thimme, Markus Glatzel, Marco Prinz, Bertram Beng- pazhooh, Alina Seletska, Stephan A Mayer, Michel Torbey. J Stroke of vascular dementia. Front. Neurol. 8:233. 2017.
sch. Deep spatial profiling of human COVID-19 brains reveals Cerebrovasc Dis 2020 24) Siracusa R, Paterniti I, Impellizzeri D, Cordaro M, Crupi R, Navarra M,
neuroinflammation with distinct microanatomical micro- 15) Di Stadio Arianna, D’Ascanio Luca, La Mantia Ignazio, Ralli Massimo, Cuzzocrea S, Esposito E. The Association of Palmitoylethanola-
glia-T-cell interactions. doi: 10.1016/j.Immunity.2021 and Brenner Michael J. Parosmia after COVID-19: Olfactory Trai- mide with Luteolin Decreases Neuroinflammation and Stimu-
4) Marcel Klein, Christian Lohr and Damian Droste. Age-Dependent ning, Neuroinflammation and Distortions of Smell. European lates Autophagy in Parkinson’s Disease Model. CNS Neurol
Heterogeneity of Murine Olfactory Bulb Astrocytes. Frontiers in Review for Medical and Pharmacological Sciences • 2021 Disord Drug Targets. 2015
Aging Neuroscience. 2020 16) Elisabeth B.Lucassen, AnthonyTurel, AmyKnehans, XuemeiHuang, Paul 25) Facci L, Barbierato M, Fusco M, Giusti P, Zusso M. Co-Ultramicro-
5) Zhida Su, Cheng He. Olfactory ensheathing cells: Biology in neu- Eslinger. Olfactory dysfunction in Multiple Sclerosis: A scoping nized Palmitoylethanolamide/Luteolin-Induced Oligodendrocyte
MB8254_01 - © EPITECH Group
ral development and regeneration. Progress in Neurobiology 92 review of the literature. Multiple Sclerosis and Related Disorders 6 Precursor Cell Differentiation is Associated With Tyro3 Recep-
(2010) 517–532 2016 tor Upregulation. Front Pharmacol. 2021
6) Kim SU, de Vellis J. Microglia in health and disease. J Neurosci 17) K Knudsen, M Flensborg Damholdt, K Mouridsen, P Borghammer. 26) Assogna M, Casula EP, Borghi I, Bonnì S, Samà D, Motta C, Di Loren-
Res. 2005;81(3):302-13. Olfactory function in Parkinson’s Disease - effects of training. zo F, D’Acunto A, Porrazzini F, Minei M, Caltagirone C, Martorana A,
7) Ramírez-Ponce MP, Sola-García A, Balseiro-Gómez S, Maldonado MD, Acta Neurol Scand. 2015 Koch G. Effects of Palmitoylethanolamide Combined with Lu-
Acosta J, Alés E, Flores JA. Mast Cell Changes the Phenotype of 18) Contarini G, Franceschini D, Facci L, Barbierato M, Giusti P, Zusso M. teoline on Frontal Lobe Functions, High Frequency Oscillations,
Microglia via Histamine and ATP. Cell Physiol Biochem. 2021; A co-ultramicronized palmitoylethanolamide/luteolin compo- and GABAergic Transmission in Patients with Frontotemporal
55(1):17-32 site mitigates clinical score and disease-relevant molecular Dementia. J Alzheimers Dis. 2020
8) Ronen Reshef1, Elena Kudryavitskaya, Haran Shani-Narkiss, Batya markers in a mouse model of experimental autoimmune en- 27) Caltagirone C, Cisari C, Schievano C, Di Paola R, Cordaro M, Bru-
Isaacson, Neta Rimmerman, Adi Mizrahi, Raz Yirmiya. The role of cephalomyelitis. J Neuroinflammation. 2019 schetta G, Esposito E, Cuzzocrea S, Stroke study group. Co-ultra-
microglia and their CX3CR1 signaling in adult neurogenesis in 19) D’Ascanio L, Vitelli F, Cingolani C, Maranzano M, Brenner MJ, Di micronized palmitoylethanolamide/luteolin in the treatment of
the olfactory bulb. eLife 2017; DOI: https://doi.org/10.7554/eLi- Stadio A. Randomized clinical trial “olfactory dysfunction after cerebral ischemia: from rodent to man. Transl Stroke Res. 2016
fe.30809 COVID-19: olfactory rehabilitation therapy vs. intervention 28) Di Stadio Arianna, D’Ascanio Luca, Vaira Luigi Angelo, Cantone Elena,
9) Jeremiah A. Alt, Xuan Qin, Abigail Pulsipher, Quinn Orb, BS, Richard treatment with Palmitoylethanolamide and Luteolin”: prelimi- De Luca Pietro, Cingolani Cristina, Motta Gaetano, De Riu Giacomo,
R. Orlandi, Jianxing Zhang, Austin Schults, Wanjian Jia, Angela P. nary results. Eur Rev Med Pharmacol Sci. 2021 Vitelli Federica, Spriano Giuseppe, De Vincentis Marco, Camaioni
Presson, Glenn D. Prestwich and Siam Oottamasathien. Topical ca- 20) Petrosino S, Cordaro M, Verde R, Schiano Moriello A, Marcolongo G, Angelo, La Mantia Ignazio, Ferreli Fabio, and Brenner Michael J.,
thelicidin (LL-37) an innate immune peptide induces acute Schievano C, Siracusa R, Piscitelli F, Peritore AF, Crupi R, Impellizze- M.D.Anti-neuroinflammatory Therapy with Olfactory Training
olfactory epithelium inflammation in a mouse model. Interna- ri D, Esposito E, Cuzzocrea S, Di Marzo V. Oral Ultramicronized for Persistent COVID-19 Anosmia: A Multicenter, Double-Blind,
tional Forum of Allergy & Rhinology, 2015 Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Placebo-Controlled Randomized Trial. Submitted to.
10) Skaper SD, Giusti P, Facci L. Microglia and mast cells: two tracks Anti-hyperalgesic Effect. Front. Pharmacol. 2018 29) Manni B, Federzoni L, Zucchi P, Fabbo A. Co-ultraPEALut Effect on
on the road to neuroinflammation. FASEB J. 2012 21) Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A. Nerve Mild Cognitive Impairment: A Retrospective Observational
11) Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé growth factor: from neurotrophin to neurokine. Trends Neurosci. Study. Acta Scientific Neurology giu 2021
M, Talbot PJ. Human Coronaviruses and Other Respiratory Vi- 1996